Resources

DaVita has agreed to pay the government more than $400 million to settle civil charges alleging DaVita paid doctors kickbacks so that they would refer patients to DaVita’s dialysis centers. The total...

Why are pharmaceutical & medical kickbacks prohibited? The False Claims Act offers whistleblowers an effective way to expose and stop pharmaceutical and medical kickbacks in the healthcare system....

Phillips & Cohen’s whistleblower complaint against Adventist Health System — United States, Florida, North Carolina, Tennessee and Texas ex rel. Payne , Church and Pryor v. Adventist Health...

DaVita whistleblower David Barbetta alleged in a qui tam case that DaVita paid doctors hidden kickbacks as a way to get patient referrals for its dialysis clinics and to reduce or eliminate competition...

The power individual IRS agents have over the decision to grant whistleblower awards is one of the key “inadequacies” of the IRS’s lackluster whistleblower program, according to Phillips & Cohen...

Michael Lissack, a former investment banker for Smith Barney, was represented by Phillips & Cohen attorneys in a qui tam lawsuit he filed against more than 20 Wall Street banking firms. He alleged...

Phillips & Cohen represented Robert McCaslin, a hospital billing department employee, in a qui tam lawsuit against his former employer, Harris County Hospital District of Houston, Texas, for Medicare...

Phillips & Cohen LLP represented John Kopchinski in a qui tam lawsuit against Pfizer Inc. that alleged the company was engaged in the off-label marketing of Bextra, a painkiller, in dangerous doses...

James F. Alderson, a client of Phillips & Cohen, was a financial officer with a Montana hospital when he was told that the hospital’s management company routinely filed fraudulent cost reports with...

Phillips & Cohen represented GlaxoSmithKline whistleblowers Matthew Burke and his co-relator in a qui tam case against GlaxoSmithKline that helped win a record-setting settlement of $3 billion from...